Boomer Esiason Foundation l Cystic Fibrosis News Feed

New CF Wind Sprint Looks at Transitioning from High School to College

Episode 23 of our CF Wind Sprint series examines transitioning from high school to college with cystic fibrosis. It is the second in a three-part series on the major transitioning stages for people with CF.

Rimington Trophy Scholarship Established to Support Students with CF

The Boomer Esiason Foundation has established the Rimington Trophy Scholarship to recognize outstanding students who are living, breathing and succeeding with cystic fibrosis.

PA Doesn't Take Holidays

That's why it's the leading cause of decreased lung function in people living with cystic fibrosis. (paid advertisement)

Gilead Sciences Working to Address Supply Shortage of Cayston

Gilead Sciences says it is working to address "significant and unanticipated challenges manufacturing enough Cayston to meet demand in the United States."

PMD Healthcare Launches Personal Spirometer To Monitor Lung Function

PMD Healthcare Inc. has launched the first and only personal spirometer that enables patients with lung diseases to easily and accurately monitor their lung function any time and anywhere.

New CF Wind Sprint Looks at Transitioning from Pediatric to Adult CF Care

Episode 22 of the CF Wind Sprint series examines transitioning from pediatric to adult CF care. It is the first in a three-part series on the major transitions for people with CF.

BEF Awards 'Sacks for CF' Scholarships to Outstanding Students with Cystic Fibrosis

The Boomer Esiason Foundation has awarded prestigious "Sacks for CF" academic scholarships to 30 outstanding students with cystic fibrosis.

Sales of Team Boomer 'Vintage' Tees to Benefit Fight Against CF

Proceeds from sales of a vintage-style Team Boomer t-shirt, designed by clothing manufacturer Homage, will benefit the Boomer Esiason Foundation and the cystic fibrosis community.

New Podcast: Colleen Caul's 'Run for Roses'

The Boomer Esiason Foundation's latest video podcast traces Colleen Caul's "Run for Roses" � her 65-day running journey from St. Louis to New York City. Caul's project aims to boost awareness of cystic fibrosis, raises funds toward a cure, and share stories of the CF community.

Vertex Planning Additional KALYDECO� Clinical Trials in 2012

Vertex Pharmaceuticals is planning additional studies of KALYDECO� in children with CF and in people with CF who have certain mutationsnot previously evaluated. Pending feedback from regulatory agencies, it plans to begin three studies in mid-2012.